Answers are grounded in this paper and cite their sources.
Objectives: Immunoreactant load was assessed by using lymphocyte response assay [LRA] with cell response/blastogenic mixed cell culture to determine if substitution of reactive items would be associated with remission of symptoms in subjects with fibromyalgia syndrome [FMS].Methods: Fibromyalgia subjects [N = 51] were assigned to a control [C: N = 11] or treatment [T: N = 40] group; C maintained usual life-styles and T, after LRA testing, underwent a program of substitution and nutritional repletion with metabolic intermediates. All subjects participated in biweekly support groups and completed questionnaires [0 months, three months, and six months] to document changes.Results: After six months T experienced 50% less pain, 70% less depression, 50% more energy, and 30% less stiffness, whereas C reported an increase in pain and depression, and comparable levels of stiffness and energy as compared to pre-program levels.Conclusions: These data suggest that reducing the immunoreactant load in FMS, while stimulating repair, may help re-establish homeostasis and neuroimmune hormonal control
No takes yet. Share an insight, caveat, or question.
Deuster et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: